These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 33509178)
1. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis. Song Y; Yang K; Sun T; Tang R BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178 [TBL] [Abstract][Full Text] [Related]
2. Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinoma. Xu Y; She Y; Li Y; Li H; Jia Z; Jiang G; Liang L; Duan L Biomed Pharmacother; 2020 May; 125():109859. PubMed ID: 32036209 [TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of genomic, epigenomic and transcriptomic data identified molecular subtypes of esophageal carcinoma. Ma M; Chen Y; Chong X; Jiang F; Gao J; Shen L; Zhang C Aging (Albany NY); 2021 Feb; 13(5):6999-7019. PubMed ID: 33638948 [TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of genomic and epigenetic regulation of endometrial cancer. Zhong Q; Fan J; Chu H; Pang M; Li J; Fan Y; Liu P; Wu C; Qiao J; Li R; Hang J Aging (Albany NY); 2020 May; 12(10):9260-9274. PubMed ID: 32412912 [TBL] [Abstract][Full Text] [Related]
5. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma. Zhao Y; Gao Y; Xu X; Zhou J; Wang H BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346 [TBL] [Abstract][Full Text] [Related]
6. Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinoma. Zheng M; Hu Y; Gou R; Wang J; Nie X; Li X; Liu Q; Liu J; Lin B Aging (Albany NY); 2019 Jun; 11(12):4198-4215. PubMed ID: 31257224 [TBL] [Abstract][Full Text] [Related]
7. Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer. Kong L; Liu P; Zheng M; Xue B; Liang K; Tan X Epigenomics; 2020 Mar; 12(6):507-524. PubMed ID: 32048534 [No Abstract] [Full Text] [Related]
8. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma. Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460 [TBL] [Abstract][Full Text] [Related]
9. Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma. Chen W; Cheng P; Jiang J; Ren Y; Wu D; Xue D Aging (Albany NY); 2020 Jul; 12(13):12703-12725. PubMed ID: 32639949 [TBL] [Abstract][Full Text] [Related]
10. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis. Mo W; Ding Y; Zhao S; Zou D; Ding X PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive data analysis of genomics, epigenomics, and transcriptomics to identify specific biomolecular markers for prostate adenocarcinoma. Ye C; Wang H; Li Z; Xia C; Yuan S; Yan R; Yang X; Ma T; Wen X; Yang D Transl Androl Urol; 2021 Jul; 10(7):3030-3045. PubMed ID: 34430406 [TBL] [Abstract][Full Text] [Related]
12. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma. Huang Z; Li B; Guo Y; Wu L; Kou F; Yang L Front Immunol; 2021; 12():723172. PubMed ID: 34539658 [TBL] [Abstract][Full Text] [Related]
13. Integrated Analysis of Multiomics Data Identified Molecular Subtypes and Oxidative Stress-Related Prognostic Biomarkers in Glioblastoma Multiforme. Ma Y; Xi Z Oxid Med Cell Longev; 2022; 2022():9993319. PubMed ID: 36193073 [TBL] [Abstract][Full Text] [Related]
14. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data. Zhong Q; Lu M; Yuan W; Cui Y; Ouyang H; Fan Y; Wang Z; Wu C; Qiao J; Hang J J Transl Med; 2021 Feb; 19(1):58. PubMed ID: 33557879 [TBL] [Abstract][Full Text] [Related]
15. Multi-omics analysis of copy number variations of RNA regulatory genes in soft tissue sarcoma. Wang X; Han Y; Li J; Hong D; Xue Z; Huang H; Du Z; Hou Y; Li H; Li H; Liao H; Xie X; Ding C Life Sci; 2021 Jan; 265():118734. PubMed ID: 33166590 [TBL] [Abstract][Full Text] [Related]
16. Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation. Zheng M; Hu Y; Gou R; Nie X; Li X; Liu J; Lin B Biomed Pharmacother; 2020 Apr; 124():109810. PubMed ID: 32000042 [TBL] [Abstract][Full Text] [Related]
17. Multi-Omics Integrative Analysis Uncovers Molecular Subtypes and mRNAs as Therapeutic Targets for Liver Cancer. Shen Y; Xiong W; Gu Q; Zhang Q; Yue J; Liu C; Wang D Front Med (Lausanne); 2021; 8():654635. PubMed ID: 34109194 [No Abstract] [Full Text] [Related]
18. A Prognostic Molecular Signature of N⁶-Methyladenosine Methylation Regulators for Soft-Tissue Sarcoma from The Cancer Genome Atlas Database. Hou M; Guo X; Chen Y; Cong L; Pan C Med Sci Monit; 2020 Dec; 26():e928400. PubMed ID: 33370249 [TBL] [Abstract][Full Text] [Related]
19. Identification of 5 Gene Signatures in Survival Prediction for Patients with Lung Squamous Cell Carcinoma Based on Integrated Multiomics Data Analysis. Ma H; Tong L; Zhang Q; Chang W; Li F Biomed Res Int; 2020; 2020():6427483. PubMed ID: 32596344 [TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer. Woo HG; Choi JH; Yoon S; Jee BA; Cho EJ; Lee JH; Yu SJ; Yoon JH; Yi NJ; Lee KW; Suh KS; Kim YJ Nat Commun; 2017 Oct; 8(1):839. PubMed ID: 29018224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]